Trade-Related Aspects of Intellectual Property Rights - Information for Review of Art. 27.3(b) (Patentable Subject Matter)

1. To what extent are inventions concerning plants or animals, whether products or processes, patentable under your country's law, if they meet the conditions for patentability stipulated in Article 27.1 of the TRIPS Agreement?

2. Where any such inventions are not patentable, even if they meet these conditions:

To what extent is this due to per se exclusions from patentability?

To what extent is this based on other grounds (for example because conditions for patentability other than those stipulated in Article 27.1 are not met or in order to protect ordre public or morality (see Article 27.2 of the Agreement))?

3. Please describe any specific provisions, guidelines, final judicial decisions and administrative rulings of general application concerning the application of the conditions for patentability stipulated in Article 27.1 to subject matter addressed by Article 27.3(b).

4. Where plant varieties are not as such patentable subject matter under your country's law, please indicate the extent to which the scope of protection under patents for inventions concerning plants can nevertheless embrace plant varieties or a botanical taxon whose plants express a trait covered by the claims of a patent.

5. Please provide any definitions used under your country's law with regard to subject matter specifically excluded from patentability or specifically patentable (e.g. micro-organisms, microbiological processes, non-biological processes, plant varieties).

6. To what extent is subject matter that is identical to what occurs in nature patentable under your country's law?

7. Explain the requirements under your country's law for ensuring adequate disclosure of the patentable inventions referred to above.

8. What rights are conferred upon owners of the patents referred to above? Are product and process patents subject to the same rules as other patents? Do they benefit from the same protection as stipulated in Article 28 of the TRIPS Agreement?

9. Are there any specific exceptions to these rights (affecting the scope or duration of the patents referred to above)? To what extent are exceptions, available in respect of plant variety rights (e.g. those referred to under question B.4(i) below), available in respect of rights conferred upon patent owners?

10. Are there any specific provisions under your country's law for compulsory licensing in respect of the patents referred to above?

N.B. Please ensure that your responses to the questions above cover each category of subject matter specified in Article 27.3(b), namely micro-organisms, essentially biological processes for the production of plants or animals, microbiological processes, non-biological processes, plant varieties and other inventions concerning plants or animals.

B. Protection of Plant Varieties

1. Does your country's law provide for the protection of plant varieties by plant breeder's rights, plant patents or any other sui generis system for the protection of plant varieties?

2. (a) If your country is a party to the International Convention for the Protection of New Varieties of Plants (UPOV), please indicate which Act or Acts of the UPOV Convention your country has signed; which it has ratified; to which it has acceded; and to the standards of which its law conforms but to which it has not (yet) adhered.

(b) If your country is not a party to the UPOV Convention, does the protection offered to plant varieties under your country's law conform to the standards of any of the Acts of the UPOV Convention and, if so, which?

3. Please indicate whether concurrent protection under your country's plant variety protection law and its patent law is available (see also question A.4 above).

4. Please provide the following details of your country's sui generis system for the protection of plant varieties:
(a) the relevant laws and regulations and, if they have been notified to the Council for TRIPS, a reference to the relevant WTO documents;

(b) the definition of "plant variety";

(d) the extent to which subject matter that is already known to the public or identical to what occurs in nature is protectable under your country's sui generis system for the protection of plant varieties;

(e) the extent to which protection can be based on characteristics of germplasm, as opposed to characteristics of plant varieties derived from such germplasm;

(f) who is entitled to the rights;

(g) the procedure for the acquisition of rights, including the authority in charge of administering the rights;

(h) the rights conferred;

(i) exceptions to the rights conferred;

acts performed for research or experimental purposes;
acts performed to develop new varieties of plants;
acts performed to commercialize such newly developed varieties;
any "farmer's privilege" (e.g. acts performed by a farmer on his own land in respect of seed saved from the previous harvest);
acts done privately and for non-commercial purposes;
compulsory licensing.

(j) the duration of protection;

(k) transfer of rights;

(l) enforcement of the rights.

Representative Questions for TRIPS 27.3(b) Review Submitted by the Delegations of Canada, the European Union (formerly European Communities), Japan and the United States

A. Patent System Questions

1. In your territory, is there any basis for denying a patent on an invention consisting of an entire plant or animal that is novel and involves an inventive step?

No, it is not directly prohibited in the Patents Act to grant a patent for plants and animals, per se. However, according to Article 1(4)(2) of the Icelandic Patents Act No. 17/1991, a patent shall not be granted for plant or animal varieties.

2. If the answer to question 1 is yes, please respond to the following questions:
(a) Does your patent system exclude entire plants or animals as inventions? If it does, please cite the legal basis for this.

(No reply necessary.)

(b) If your patent system does recognize entire plants and animals as inventions, does it exclude all such inventions from being patentable subject matter, or does it only exclude certain types of plants or animals? If it excludes all, please cite the legal basis for their exclusion (e.g. lack of industrial applicability). If it excludes only certain types, please identify the categories or characteristics of inventions that are excluded and cite the legal basis for their exclusion.

(No reply necessary.)

(c) Is there any other basis in your law that precludes the grant of a patent on any categories of plant or animal inventions that otherwise are novel, involve an inventive step and are capable of industrial application? If so, please cite the legal basis for that exclusion from patent eligibility.

(No reply necessary.)

3. Other than with respect to subject matter you defined as being ineligible to be patented under question (2), is it possible in your territory to obtain a patent claim defined in any of the following ways?
(a) A patent claim that is not limited to a specific plant or animal variety.

Yes, it is possible.

(b) A patent claim that is expressly limited to a plant or animal variety.

No, it is not possible.

(c) A patent claim that is expressly limited to a group of plants or animals, where the group is defined through reference to a shared characteristic such as incorporation of a particular gene.

Yes, it is possible.

(d) If the answers you provide to question (3)(a) to (c) vary, please provide the definitions of a "plant variety" and an "animal variety" that are used by your examining authority.

(No reply provided.)

4. Is it possible to obtain a patent in your territory on a microorganism that is novel, involves an inventive step and is capable of industrial application? If not, please identify the legal basis under which these inventions are deemed ineligible to be patented.

According to Article 1(4)(2) of the Icelandic Patents Act No. 17/1991, it is possible to obtain a patent for microbiological processes and products resulting from such processes. It is not directly prohibited in the Patents Act to grant a patent for a micro-organism.

5. Is it possible to obtain a patent in your territory on an essentially biological process for the production of a plant or animal (i.e. a process limited to those acts that are necessary for sexual or asexual reproduction of a plant or animal)? If not, please identify the legal basis under which a patent on such a process would be denied.

No, according to Article 1(4)(2) of the Icelandic Patents Act, patents shall not be granted for "essentially biological processes for the production of plants or animals".

6. Is it possible to obtain a patent in your territory covering subject matter that is identical to that found in nature (e.g. a plant or animal in its natural state)?

Yes, if the invention is novel, involves an inventive step and is susceptible to industrial application.

B. Plant Variety Protection Systems

7. Do the laws applicable to your territory provide for a sui generis form of protection for a new plant variety?

On 19 May 2000, a bill on plant variety protection was passed in the parliament. The Icelandic Plant Variety Protection Act No. 58/2000 provides a sui generis form of protection for a new plant variety.

8. If the answer to question 7 is "yes", does that protection conform to the standards defined in one of the Acts of the International Convention for the Protection of New Varieties of Plants (UPOV)?

Yes, the provisions of the Icelandic Plant Variety Protection Act correspond to the International Convention for the Protection of New Varieties of Plants (UPOV) from 1991.

9. If the answer to question 8 is "yes", please specify the Act of the UPOV Convention upon which your legislation is based (i.e. the 1991 Act, the 1978 Act or the 1961/1972 Act).

The Plant Variety Protection Act is based on the 1991 Act of the UPOV Convention.

10. If sui generis protection for plant varieties is provided in your territory, would any of the following acts require the prior authorization of the right holder:
(a) acts performed for research or experimental purposes, or to develop new varieties of plants;

No, an authorization is not required. According to Article 18(2) of the Plant Variety Protection Act, the breeder's right shall not extend to utilization for experimental purposes.

(b) acts performed to commercially exploit a variety distinct from the protected variety but sharing its essential characteristics;

Yes, an authorization is required. According to Article 16 of the Plant Variety Protection Act, the protection shall include a variety which is essentially derived from the registered variety. A plant variety is considered essentially derived from a variety if it is predominantly derived from the initial variety or from a variety that is itself predominantly derived from the initial variety, while retaining the expression of the essential characteristics that result from the genotype or combination of genotypes of the initial variety.

(c) acts performed by a farmer of harvesting seed from his planting of a protected variety legitimately obtained, storage of that seed, and replanting of that seed on the farmer’s land.

No, an authorization is not required. According to Article 18(1) of the Plant Variety Protection Act, protection does not extend to private utilization for non-commercial purposes. According to Article 17(3), the Minister can set rules to oblige parties propagating varieties of specifically prescribed species, exclusively for use in their own operations, to pay licence fees.

If prior authorization is not required for any of the above examples of activities, is there any requirement that the party undertaking the specified actions provide the right holder with remuneration in any form?

According to Article 18(1) of the Plant Variety Protection Act, an authorization is not required for private utilization for non-commercial purposes. According to Article 17(3) the Minister can set rules to oblige parties propagating varieties of specifically prescribed species, exclusively for use in their own operations, to pay licence fees.

11. Can protection be obtained for a plant variety that was known to the public, or was publicly available, prior to the application for sui generis protection for that plant variety, and, if so, under what conditions (i.e. what are the time-limits during which public disclosure or availability will not preclude the grant of protection).

According to Article 2(1)(4) of the Plant Variety Protection Act, a protection can be granted if the variety is new, i.e. propagating or harvested material of the variety has not been sold or offered for public sale or otherwise disposed of, by or with the consent of the breeder, for purposes of commercial utilization of the variety: - in Iceland, earlier than one year before the above-mentioned date; or - in another country, earlier than four years or, in the case of trees or of vines, earlier than six years before the above-mentioned date. According to Article 2(2), a variety is considered to be known if it has been sold or offered for public sale, is registered in an official variety list or is generally known through other means.

12. Can protection be predicated on identification of an unexpressed gene, on an unexpressed set of genes present in the genome of the plant variety, or on the characteristics of germplasm, rather than the expressed characteristics of plant varieties derived from such genes or germplasm?

No.